<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/47A19BC3-1395-402D-8C69-FB62D261798E"><gtr:id>47A19BC3-1395-402D-8C69-FB62D261798E</gtr:id><gtr:name>Federal University of Minas Gerais</gtr:name><gtr:address><gtr:line1>Av. Antonio Carlos, 6627, Pampulha</gtr:line1><gtr:line2>6627 - Pampulha</gtr:line2><gtr:postCode>31270-901</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Brazil</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/6DE7B8D1-A680-4E2C-BBBC-E45824A00BD8"><gtr:id>6DE7B8D1-A680-4E2C-BBBC-E45824A00BD8</gtr:id><gtr:name>Tropical Medicine Foundation Doctor Heitor Vieira Dourado</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/545D7D1C-FA43-4709-BB37-8D7A3116AE80"><gtr:id>545D7D1C-FA43-4709-BB37-8D7A3116AE80</gtr:id><gtr:name>Federal University of Amazonas</gtr:name><gtr:address><gtr:line1>AV. Rodrigo Otavio 3000</gtr:line1><gtr:region>Outside UK</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/57150975-2FFC-442F-A99E-ABD25A46F8D2"><gtr:id>57150975-2FFC-442F-A99E-ABD25A46F8D2</gtr:id><gtr:name>Pasteur Institute, Paris</gtr:name></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/055EA8B7-2C66-4FF5-96DD-63FA3AA7D0B7"><gtr:id>055EA8B7-2C66-4FF5-96DD-63FA3AA7D0B7</gtr:id><gtr:name>London Sch of Hygiene and Trop Medicine</gtr:name><gtr:department>Infectious and Tropical Diseases</gtr:department><gtr:address><gtr:line1>Keppel Street</gtr:line1><gtr:postCode>WC1E 7HT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/055EA8B7-2C66-4FF5-96DD-63FA3AA7D0B7"><gtr:id>055EA8B7-2C66-4FF5-96DD-63FA3AA7D0B7</gtr:id><gtr:name>London Sch of Hygiene and Trop Medicine</gtr:name><gtr:address><gtr:line1>Keppel Street</gtr:line1><gtr:postCode>WC1E 7HT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/47A19BC3-1395-402D-8C69-FB62D261798E"><gtr:id>47A19BC3-1395-402D-8C69-FB62D261798E</gtr:id><gtr:name>Federal University of Minas Gerais</gtr:name><gtr:address><gtr:line1>Av. Antonio Carlos, 6627, Pampulha</gtr:line1><gtr:line2>6627 - Pampulha</gtr:line2><gtr:postCode>31270-901</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Brazil</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/6DE7B8D1-A680-4E2C-BBBC-E45824A00BD8"><gtr:id>6DE7B8D1-A680-4E2C-BBBC-E45824A00BD8</gtr:id><gtr:name>Tropical Medicine Foundation Doctor Heitor Vieira Dourado</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/545D7D1C-FA43-4709-BB37-8D7A3116AE80"><gtr:id>545D7D1C-FA43-4709-BB37-8D7A3116AE80</gtr:id><gtr:name>Federal University of Amazonas</gtr:name><gtr:address><gtr:line1>AV. Rodrigo Otavio 3000</gtr:line1><gtr:region>Outside UK</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/57150975-2FFC-442F-A99E-ABD25A46F8D2"><gtr:id>57150975-2FFC-442F-A99E-ABD25A46F8D2</gtr:id><gtr:name>Pasteur Institute, Paris</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/B13A2953-E9EA-44CB-A5D9-75DE763F0FA8"><gtr:id>B13A2953-E9EA-44CB-A5D9-75DE763F0FA8</gtr:id><gtr:firstName>Chris</gtr:firstName><gtr:surname>Drakeley</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/3A2DC37A-30B1-4A1A-87B8-C29916E02C3F"><gtr:id>3A2DC37A-30B1-4A1A-87B8-C29916E02C3F</gtr:id><gtr:firstName>Kevin</gtr:firstName><gtr:surname>Tetteh</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=MR%2FM02623X%2F1"><gtr:id>949602CB-802F-4975-A261-EB1804CE8BDD</gtr:id><gtr:title>Newton001 Sero-surveillance to estimate the burden of Plasmodium vivax and P. falciparum infection in Latin America</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>MR/M02623X/1</gtr:grantReference><gtr:abstractText>Malaria elimination requires that activities focus on reducing parasite carriage within communities in addition to treating those sick with the disease. However, as malaria transmission levels decrease, it becomes harder to identify individuals who might be carrying parasites using conventional methods (microscopy, rapid diagnostic tests), as many of these infections will be of low density and asymptomatic. Therefore, there is a need for innovative and affordable approaches to identify likely parasite carriers and the areas where they reside. One approach is serological surveillance. A malaria infection will leave an antibody 'footprint' in the serum of the human host that will last longer than the infection itself. Detection of these antibodies is an additional sensitive and specific approach to measure a population's level of exposure to infection. Using antibodies in this way has recently been revitalised by researchers at LSHTM as a method to estimate malaria burden with considerable accuracy.

Antibody measures have been shown to correlate with other conventional estimates of malaria burden (entomological, parasitological and clinical). It has also been shown that by evaluating the antibody responses and age of individuals it is possible to recreate the history of exposure to malaria. This facet allows a retrospective examination of the effect of malaria control interventions in a given locality. This work has primarily been conducted in African settings where Plasmodium falciparum is predominant, however a more recent analysis of samples from Para state, Brazil showed the approach was applicable in this setting. Therefore, the aim of this project is to extend this work by assembling the current evidence on sero-epidemiology and antibody dynamics in Latin America and extending this with novel antibody targets and analytical approaches.

The expected results of this project are to promote better understanding of the current landscape of sero-surveillance evidence in Latin America and to identify research needs to be addressed in future studies. These studies will be formulated to further strengthen collaboration between participating institutions in developing reliable sero-surveillance methods to estimate species-specific malaria burden in the region, target control methods and ultimately contribute to malaria elimination in the region. This proposal specifically addresses the need for rapid and reliable tools and strategies to measure malaria burden and we believe it will provide considerable information to guide policy makers in Latin America.</gtr:abstractText><gtr:technicalSummary>The project comprises four main parts:
1. Systematic review of seroepidemiology studies of malaria in Latin America. Data will be extracted on antigenic targets, serological measurements, malaria transmission intensity, demographic and geographical characteristics and study design. Meta-analysis will evaluate the correlation between serological measurements obtained with malaria transmission data from each location. A preliminary map of malaria sero-surveillance will be generated using geostatistical tools. Further evaluation will be made on studies which could provide data on differing serological patterns between new Pv infection and relapse episodes.
2. Repository of sero-survey samples from Brazil. A library of samples will be collated in Brazil and used to identify a broader range of antibody markers for future study.
3. Evaluation of antigenic targets. We will identify and evaluate antigenic sources previously described for assays in the review and reproduce these and newer candidate antigens using SLIC. Newer antigenic candidates will be identified in existing databases, including next generation sequence data. Purified antigens will be analysed by SDS PAGE and Western blot, using Pv positive control sera, to determine protein integrity and screen for immunoreactivity. Promising candidates will be further assayed primarily by ELISA, later with Luminex, against endemic sera identified above and archived in London.
4. Capacity &amp;amp; partnership strengthening. An initial meeting in Manaus will harmonize study design and methods. A second meeting will be held in November to: present and discuss results of the systematic review and sample repository; identify knowledge gaps in sero-surveillance in Latin America and plan future studies; and exchange knowledge and technology between research groups. Exchange of postdoctoral and PhD students from both countries will enable technology transfer on measurement and analysis of malaria sero-surveillance studies.</gtr:technicalSummary><gtr:potentialImpactText>N/A</gtr:potentialImpactText><gtr:fund><gtr:end>2017-03-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2015-01-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>69154</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Federal University of Minas Gerais</gtr:collaboratingOrganisation><gtr:country>Brazil, Federative Republic of</gtr:country><gtr:description>BRASS Collaboration</gtr:description><gtr:id>BB1648E0-6F19-4CE7-BC47-8DF1CAD80BAC</gtr:id><gtr:impact>We are still waiting for our Brazilian partners to receive their government funding in-country. When they have received the funds, we will be able to start producing outputs.</gtr:impact><gtr:outcomeId>56bc7473cda723.25795542-1</gtr:outcomeId><gtr:partnerContribution>Partners at the Funda&amp;ccedil;&amp;atilde;o de Medicina Tropical Dr Heitor Vieira Dourado, UFMG and Universidade do Estado do Amazonas made large contributions to developing the collaborative project and preparing the grant application, with particular expertise in Plasmodium vivax malaria, epidemiology of malaria in Latin America, and surveillance and control interventions in the Amazon region.</gtr:partnerContribution><gtr:piContribution>This partnership describes the main BRASS project collaboration between UK and Brazilian institutions. Our team at the London School of Hygiene and Tropical Medicine co-led (with Funda&amp;ccedil;&amp;atilde;o de Medicina Tropical Dr Heitor Vieira Dourado) the development of the collaborative project and grant application, and contribute particular expertise on the use and analysis of sero-surveillance tools and strategies to quantify malaria burden and the effect of control interventions, as well as providing technology transfer and training.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Federal University of Amazonas</gtr:collaboratingOrganisation><gtr:country>Brazil, Federative Republic of</gtr:country><gtr:description>BRASS Collaboration</gtr:description><gtr:id>A5B0403B-ECB6-4D0E-8BF9-046FDF734DAF</gtr:id><gtr:impact>We are still waiting for our Brazilian partners to receive their government funding in-country. When they have received the funds, we will be able to start producing outputs.</gtr:impact><gtr:outcomeId>56bc7473cda723.25795542-3</gtr:outcomeId><gtr:partnerContribution>Partners at the Funda&amp;ccedil;&amp;atilde;o de Medicina Tropical Dr Heitor Vieira Dourado, UFMG and Universidade do Estado do Amazonas made large contributions to developing the collaborative project and preparing the grant application, with particular expertise in Plasmodium vivax malaria, epidemiology of malaria in Latin America, and surveillance and control interventions in the Amazon region.</gtr:partnerContribution><gtr:piContribution>This partnership describes the main BRASS project collaboration between UK and Brazilian institutions. Our team at the London School of Hygiene and Tropical Medicine co-led (with Funda&amp;ccedil;&amp;atilde;o de Medicina Tropical Dr Heitor Vieira Dourado) the development of the collaborative project and grant application, and contribute particular expertise on the use and analysis of sero-surveillance tools and strategies to quantify malaria burden and the effect of control interventions, as well as providing technology transfer and training.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Pasteur Institute, Paris</gtr:collaboratingOrganisation><gtr:country>France, French Republic</gtr:country><gtr:description>Institut Pasteur, Paris</gtr:description><gtr:id>0E6A0530-9D7A-4B6C-A25C-9FC112CB4C11</gtr:id><gtr:impact>None yet.</gtr:impact><gtr:outcomeId>58ca8bc6cd9725.44472644-1</gtr:outcomeId><gtr:partnerContribution>Provision of novel antigens to be screened.</gtr:partnerContribution><gtr:piContribution>Providing basic reagents and samples to evaluate antigens.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2017-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Tropical Medicine Foundation Doctor Heitor Vieira Dourado</gtr:collaboratingOrganisation><gtr:country>Brazil, Federative Republic of</gtr:country><gtr:description>BRASS Collaboration</gtr:description><gtr:id>4C2056B2-D3F4-466D-AF93-384BFD31BCAD</gtr:id><gtr:impact>We are still waiting for our Brazilian partners to receive their government funding in-country. When they have received the funds, we will be able to start producing outputs.</gtr:impact><gtr:outcomeId>56bc7473cda723.25795542-2</gtr:outcomeId><gtr:partnerContribution>Partners at the Funda&amp;ccedil;&amp;atilde;o de Medicina Tropical Dr Heitor Vieira Dourado, UFMG and Universidade do Estado do Amazonas made large contributions to developing the collaborative project and preparing the grant application, with particular expertise in Plasmodium vivax malaria, epidemiology of malaria in Latin America, and surveillance and control interventions in the Amazon region.</gtr:partnerContribution><gtr:piContribution>This partnership describes the main BRASS project collaboration between UK and Brazilian institutions. Our team at the London School of Hygiene and Tropical Medicine co-led (with Funda&amp;ccedil;&amp;atilde;o de Medicina Tropical Dr Heitor Vieira Dourado) the development of the collaborative project and grant application, and contribute particular expertise on the use and analysis of sero-surveillance tools and strategies to quantify malaria burden and the effect of control interventions, as well as providing technology transfer and training.</gtr:piContribution><gtr:sector>Hospitals</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>F15EAE61-1FB3-448A-92B9-A0D9B2771A41</gtr:id><gtr:title>A systematic review on malaria sero-epidemiology studies in the Brazilian Amazon: insights into immunological markers for exposure and protection.</gtr:title><gtr:parentPublicationTitle>Malaria journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b58809edd32e682df73cad242a3e15d9"><gtr:id>b58809edd32e682df73cad242a3e15d9</gtr:id><gtr:otherNames>Folegatti PM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1475-2875</gtr:issn><gtr:outcomeId>58c7d6ce795879.77971760</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>62D8B69B-55AA-4955-83EE-224C302F6EFB</gtr:id><gtr:title>Allele-specific antibodies to Plasmodium vivax merozoite surface protein-1: prevalence and inverse relationship to haemoglobin levels during infection.</gtr:title><gtr:parentPublicationTitle>Malaria journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/38087646cbf16c6d5bb226f5a3f786de"><gtr:id>38087646cbf16c6d5bb226f5a3f786de</gtr:id><gtr:otherNames>Sep?lveda N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1475-2875</gtr:issn><gtr:outcomeId>58c7d6cea86c28.09824074</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">MR/M02623X/1</gtr:identifier></gtr:identifiers><gtr:healthCategories/><gtr:researchActivities/><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes><gtr:rcukProgramme><gtr:id>C11BDEA9-7D9D-4728-B6A9-31032921B328</gtr:id><gtr:text>Newton</gtr:text></gtr:rcukProgramme></gtr:rcukProgrammes></gtr:project></gtr:projectComposition></gtr:projectOverview>